Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy

NEUROBIOLOGY OF DISEASE

卷:149

Article

Welzel, Lisa¹  Bergin, David H.^1,4  Schidlitzki, Alina¹  Twele, Friederike¹  Johne, Marie^1,2  Klein, Pavel³  Loescher, Wolfgang^1,2 

[1] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany

[2] Ctr Syst Neurosci, Hannover, Germany

[3] Midatlant Epilepsy & Sleep Ctr, Bethesda, MD USA

[4] Univ Oxford, MRC Brain Network Dynam Unit, Oxford, England

关键词: Seizures;    kainate;    hippocampus;    neuroinflammation;    blood-brain barrier;   

DOI  :  10.1016/j.nbd.2020.105227

来源: Elsevier

【 摘 要 】

Epileptogenesis, the gradual process that leads to epilepsy after brain injury or genetic mutations, is a complex network phenomenon, involving a variety of morphological, biochemical and functional brain alterations. Although risk factors for developing epilepsy are known, there is currently no treatment available to prevent epilepsy. We recently proposed a multitargeted, network-based approach to prevent epileptogenesis by rationally combining clinically available drugs and provided first proof-of-concept that this strategy is effective. Here we evaluated eight novel rationally chosen combinations of 14 drugs with mechanisms that target different epileptogenic processes. The combinations consisted of 2-4 different drugs per combination and were administered systemically over 5 days during the latent epileptogenic period in the intrahippocampal kainate mouse model of acquired temporal lobe epilepsy, starting 6 h after kainate. Doses and dosing intervals were based on previous pharmacokinetic and tolerability studies in mice. The incidence and frequency of spontaneous electrographic and electroclinical seizures were recorded by continuous (24/7) video linked EEG monitoring done for seven days at 4 and 12 weeks post-kainate, i.e., long after termination of drug treatment. Compared to vehicle controls, the most effective drug combination consisted of low doses of levetiracetam, atorvastatin and ceftriaxone, which markedly reduced the incidence of electrographic seizures (by 60%; p<0.05) and electroclinical seizures (by 100%; p<0.05) recorded at 12 weeks after kainate. This effect was lost when higher doses of the three drugs were administered, indicating a synergistic drug-drug interaction at the low doses. The potential mechanisms underlying this interaction are discussed. We have discovered a promising novel multitargeted combination treatment for modifying the development of acquired epilepsy.